Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03092609 · ClinicalTrials.gov registry record · NA
Neuroplasticity in an Extended Amygdala Network as a Target Mechanism for Attention Bias Modification Outcome
A NA study of Anxiety, sponsored by Northern Michigan University.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
- 1
- Study location
NCT03092609 is a NA study of Anxiety that has completed, run by Northern Michigan University. The registered enrollment target is 119 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03092609, a NA study of Anxiety, has completed, sponsored by Northern Michigan University.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
- 1
- Study location
Study Summary
Anxiety disorders are one of the most common psychological disorders. Underlying anxiety is an increased attentional bias to threat, which has been identified as a causal contributor in the development of anxiety. Given this causal relationship, attention bias modification was introduced as a treatment option where anxiety is reduced by training individuals to direct their attention away from threat and thereby decreasing anxiety. Over a decade of research using this approach, called attention bias modification (ABM), suggests that overall the approach is effective in reducing anxiety. Although ABM appears to be a very promising treatment option for anxiety, there are several factors limiting the effectiveness of ABM. These include the recognition of individual-level needs and a known underlying mechanism of action by which ABM is effective. Neuroimaging evidence suggests that attentional bias to visual threat is associated with a network of brain regions including the amygdala, anterior cingulate cortex, and visual cortex. In human participants, experience-dependent neuroplasticity is visible in voxel-based morphometry based measures of gray matter volume following training. Recently, voxel-based morphometry measures of gray matter volume have been linked to dendritic spine density-a known cellular mechanism for learning-related neuroplasticity. Thus, voxel-based morphometry measures are ideally suited to measure learning-related neuroplasticity following attention bias modification. In this proposal participants' level of attentional bias, anxiety, and gray matter volume will be measured before and after completing six weeks of attention bias modification training (N = 50) or attention control training (N= 50). The proposal aims to (1) establish that pre-treatment bias predicts variability in gray matter volume in the extended amygdala and anterior cingulate cortex, (2) assess the extent to which reduced extended amygdala and anterior cingulate cortex gray matter
Conditions Studied
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL Attention Bias Modification
Study Locations (1)
Michigan
- Northern Michigan University - Marquette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2017-12-15 |
| Est. Completion | 2020-03-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03092609
The ClinicalTrials.gov registry entry for NCT03092609 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (73% lower). The listed sponsor is Northern Michigan University, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Attention Control is the first listed.
NCT03092609 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03092609 about?
NCT03092609 is a clinical study titled "Neuroplasticity in an Extended Amygdala Network as a Target Mechanism for Attention Bias Modification Outcome". Anxiety disorders are one of the most common psychological disorders. Underlying anxiety is an increased attentional bias to threat, which has been identified as a causal contributor in the development of anxiety. Given this causal relationship, attention bias modification was introduced as a treatm...
What is the current status of trial NCT03092609?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2017-12-15. Estimated completion is 2020-03-14.
What conditions does trial NCT03092609 study?
This clinical trial studies the following conditions: Anxiety.
What interventions are being tested in trial NCT03092609?
The interventions under investigation include: Attention Control (BEHAVIORAL), Attention Bias Modification (BEHAVIORAL).
Who is sponsoring clinical trial NCT03092609?
This trial is sponsored by Northern Michigan University, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03092609 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.